We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
+29.1%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$976M
AUM Growth
+$65.1M
(+7.2%)
Cap. Flow
+$24.5M
Cap. Flow
% of AUM
2.51%
Top 10 Holdings %
Top 10 Hldgs %
37.09%
Holding
100
New
33
Increased
11
Reduced
19
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRAL
GRAIL Inc
GRAL
|
+$20M |
| 2 |
Fluence Energy
FLNC
|
+$16.7M |
| 3 |
Intuitive Surgical
ISRG
|
+$16.2M |
| 4 |
Hims & Hers Health
HIMS
|
+$14.6M |
| 5 |
Illumina
ILMN
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLNO
Soleno Therapeutics
SLNO
|
+$19.3M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
+$13.2M |
| 3 |
iShares Global Clean Energy ETF
ICLN
|
+$12.8M |
| 4 |
Icon
ICLR
|
+$11.7M |
| 5 |
Sportradar
SRAD
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.52% |
| 2 | Miscellaneous | 25.09% |
| 3 | Technology | 18.45% |
| 4 | Industrials | 16.44% |
| 5 | Consumer Discretionary | 6.87% |
No holdings matched the selected filter criteria.
Similar funds
PHP
ACM
FM
PFGIA
PAMI
SI
ZI
RIA
Kingdon Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Kingdon Capital Management held 100 positions worth $976M, up 7.2% from $911M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Kingdon Capital Management's Q2 2026 filing shows 33 new, 11 increased, 19 reduced and 26 closed positions. Its largest new stake was GRAIL Inc: 340,000 shares worth $23.2M. The largest sale was Soleno Therapeutics, an estimated $19.3M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Technology.
- Kingdon Capital Management's largest Q2 2026 buy was GRAIL Inc: 340,000 shares worth $23.2M.
- Kingdon Capital Management added most to NVIDIA in Q2 2026, an estimated $8.22M increase.
- Kingdon Capital Management's biggest Q2 2026 reduction was Flex, cutting an estimated $10.3M.
- Kingdon Capital Management fully exited Soleno Therapeutics in Q2 2026, selling an estimated $19.3M.
- Kingdon Capital Management's ten largest holdings make up 37% of its $976M portfolio in Q2 2026.
- Kingdon Capital Management opened 33 new positions and closed 26 in Q2 2026.
- Kingdon Capital Management's portfolio value rose 7.2% quarter-over-quarter to $976M.
Based on Kingdon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.